Look AHEAD Research Group, Gregg EW, Jakicic JM, et al
Lower quality protein sources may provide fewer essential amino acids, making it harder for the body to meet its needs when intake is already reduced
Reporting of limitations of observational research
n the Phase 2b PanACEA-DECODE-01 dose-finding trial, added to a backbone of bedaquiline, delamanid and moxifloxacin, pharmacokinetic-pharmacodynamic modelling suggested that it adds efficacy and that 1200 mg once daily would maximise efficacy while remaining safe, raising the prospect of averting linezolid-type toxicity in long-term treatment
J Pept Sci , 2012, 18(11): 685-690
A common question when exploring peptides is: does BPC-157 cause cancer